243 related articles for article (PubMed ID: 30549314)
1. Injecting RNA interference lentiviruses targeting the muscarinic 3 receptor gene into the bladder wall inhibits neurogenic detrusor overactivity in rats with spinal cord injury.
Shang Z; Jia C; Yan H; Cui B; Wu J; Wang Q; Gao W; Cui X; Li J; Ou T
Neurourol Urodyn; 2019 Feb; 38(2):615-624. PubMed ID: 30549314
[TBL] [Abstract][Full Text] [Related]
2. Moxibustion attenuates neurogenic detrusor overactivity in spinal cord injury rats by inhibiting M2/ATP/P2X3 pathway.
Wang L; Fu YB; Liu Y; Yang NN; Ma SM; Wang XR; Huang J; Shi GX; Yang JW; Liu CZ
Brain Res; 2022 Aug; 1788():147926. PubMed ID: 35469847
[TBL] [Abstract][Full Text] [Related]
3. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
Coelho A; Oliveira R; Cruz F; Cruz CD
Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
[TBL] [Abstract][Full Text] [Related]
4. Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats.
Matsumoto Y; Miyazato M; Yokoyama H; Kita M; Hirao Y; Chancellor MB; Yoshimura N
Urology; 2012 May; 79(5):1184.e15-20. PubMed ID: 22386753
[TBL] [Abstract][Full Text] [Related]
5. Change in urodynamic pattern and incidence of urinary tract infection in patients with traumatic spinal cord injury practicing clean self-intermittent catheterization.
Neyaz O; Srikumar V; Equebal A; Biswas A
J Spinal Cord Med; 2020 May; 43(3):347-352. PubMed ID: 30277852
[No Abstract] [Full Text] [Related]
6. Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial.
Li J; Wang J; Hu Y; Jian R; Zhao Y; Li D; Wan T; Jike W; Xu F; Huang M
Trials; 2023 Mar; 24(1):199. PubMed ID: 36932375
[TBL] [Abstract][Full Text] [Related]
7. The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-up.
Farrelly E; Lindbo L; Seiger Å
Scand J Urol; 2021 Oct; 55(5):412-418. PubMed ID: 34279177
[TBL] [Abstract][Full Text] [Related]
8. Renal deterioration after spinal cord injury is associated with length of detrusor contractions during cystometry-A study with a median of 41 years follow-up.
Elmelund M; Klarskov N; Bagi P; Oturai PS; Biering-Sørensen F
Neurourol Urodyn; 2017 Aug; 36(6):1607-1615. PubMed ID: 27813141
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
10. Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats.
Abdel-Karim AM; Barthlow HG; Bialecki RA; Elhilali MM
J Urol; 2005 Oct; 174(4 Pt 1):1488-92. PubMed ID: 16145477
[TBL] [Abstract][Full Text] [Related]
11. Conditional neuromodulation of neurogenic detrusor overactivity using transrectal stimulation in patients with spinal cord injury: A proof of principle study.
Knight SL; Edirisinghe N; Leaker B; Susser J; Craggs MD
Neurourol Urodyn; 2018 Jan; 37(1):385-393. PubMed ID: 28666061
[TBL] [Abstract][Full Text] [Related]
12. Urodynamic effects of intravenous and intrathecal administration of E-series prostaglandin 1 receptor antagonist on detrusor overactivity in rats with spinal cord injury.
Wada N; Kadekawa K; Majima T; Shimizu T; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2018 Jan; 37(1):132-137. PubMed ID: 28608967
[TBL] [Abstract][Full Text] [Related]
13. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study.
Bourbeau DJ; Gustafson KJ; Brose SW
J Spinal Cord Med; 2019 May; 42(3):360-370. PubMed ID: 29334338
[TBL] [Abstract][Full Text] [Related]
14. Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury.
Salehi-Pourmehr H; Rahbarghazi R; Mahmoudi J; Roshangar L; Chapple CR; Hajebrahimi S; Abolhasanpour N; Azghani MR
Life Sci; 2019 Mar; 221():20-28. PubMed ID: 30735734
[TBL] [Abstract][Full Text] [Related]
15. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury.
Chen SF; Jiang YH; Kuo HC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):125-133. PubMed ID: 29482913
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity.
García Fadrique G; Gallego D; Ordaz D; Climent L
Urol Int; 2020; 104(3-4):273-276. PubMed ID: 31461727
[TBL] [Abstract][Full Text] [Related]
17. Neurogenic detrusor overactivity: comparison between complete and incomplete spinal cord injury patients.
Moslavac S; Dzidic I; Kejla Z
Neurourol Urodyn; 2008; 27(6):504-6. PubMed ID: 18508334
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
19. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.
Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C
Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
Walter M; Ramirez AL; Lee AH; Rapoport D; Kavanagh A; Krassioukov AV
BMJ Open; 2018 Nov; 8(11):e024084. PubMed ID: 30467135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
